Have you or your loved ones been diagnosed with advanced cancer?

You may be eligible to participate in a advanced cancer clinical trial.

Have you or your loved ones been diagnosed with advanced cancer? You may be eligible to participate in a advanced cancer clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Advanced Cancer Clinical Trial in Philadelphia PA
NCT01655225 | Phase 1 | Interventional

Have you or your loved ones been diagnosed with advanced cancer?

You may be eligible to participate in a advanced cancer clinical trial.

Have you or your loved ones been diagnosed with advanced cancer? You may be eligible to participate in a advanced cancer clinical trial.

Active not recruiting

Male & Female

18 Years +

This study has recruited 156 Participants

The purpose of this study is to find a recommended dose level and schedule of dosing LY3023414 that can safely be taken by participants with advanced or metastatic cancer. The study will also explore the changes to various markers in blood cells and potentially tumor cells. Finally, the study will help document any antitumor activity this drug may have. In Part A of this study, participants with advanced/metastatic cancer (including lymphoma) will receive increasing doses of LY3023414. In Part B, LY3023414 will be explored in different types of cancer, including breast and lung cancer, lymphoma and mesothelioma.